Site Logo
  • About
    • About us
    • Management Team
    • Board of Directors
    • Advisory Board
  • R&D
    • Immuno-oncology
    • Technology
    • Collaborations
    • Publications
    • Posters
  • Clinical program
  • Partnering
  • Investors
    • Overview
    • The share
    • Shareholder information
    • Nomination committee
    • Largest shareholders
    • Financial calendar
    • Reports & Presentations
      • Financial Reports
      • Presentations
      • Information Document
    • Events
    • Analyst coverage
    • IR Contact
    • National Prospectus 2024
  • News
    • Press releases & other news
    • Subscribe
  • Contact

post@lytixbiopharma.com

Investors | Shareholder information
2025 Recommendation from the Nomination and Compensation Committee – Lytix Biopharma AS
Notice of Annual General Meeting - April 29, 2025
Minutes_Ordinary General Meeting_May 2024
Notice_Ordinary General Meeting_May 2024
Minutes_Extraordinary General Meeting_April 2024
Notice_Extraordinary General Meeting_April 2024
Minutes_Ordinary General Meeting_April 2023
Notice_Ordinary General Meeting_April 2023
Minutes_Ordinary General Meeting_April 2022
Notice_Ordinary General Meeting_April 2022
Minutes_Ordinary General Meeting_June 2021
National Prospectus_May 2021

investors

OverviewThe shareShareholder informationNomination committeeLargest shareholdersFinancial calendarReports & Presentations
Financial ReportsPresentationsInformation Document
EventsAnalyst coverageIR ContactNational Prospectus 2024

Cookies

Disclaimer

Privacy

Terms and Conditions

© 2025 Lytix Biopharma AS